Simple blood test may spot postpartum depression risk before symptoms start
NCT ID NCT06831968
First seen Jan 07, 2026 · Last updated Jun 22, 2026 · Updated 23 times
Summary
Researchers are testing a new blood test that might predict if a pregnant woman will develop postpartum depression (PPD). The study will enroll 500 pregnant women, take a blood sample in the third trimester, and follow them for 6 months after birth to see who develops depression. The goal is to see if the test can accurately identify those at high risk, which could lead to earlier help and support.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Inova Health System
RECRUITINGFalls Church, Virginia, 22042, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22903, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this blood test could help identify pregnant women at risk for postpartum depression, allowing for early support and monitoring.
What could go wrong
This is an early-stage observational study, not a treatment trial. The test is not yet FDA-approved, and it may not accurately predict PPD in all women.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.